Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07311733
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older
* Healthy, verified by an eligible designation on the Health History Form
Exclusion Criteria:
* Abnormal bleeding / hemophilia
* Absence of sensation in one or both arms
* Allergy to common medical materials
* Blood clotting disorder
* Currently enrolled in another clinical trial
* Current hepatitis infection or any history of hepatitis B or C
* Currently pregnant
* Daily regimen of blood thinning medication (e.g., aspirin, ibuprofen, naproxen, Coumadin®/warfarin, Eliquis®/apixaban).
* Fever at the time of study visit (≥100.4°F)
* Frequent dizziness or fainting spells, especially with needles
* History of chronic, severe anemia
* History of stroke
* HIV / Aids
* Immune deficiency disorder
* Lymphedema
* Major surgery or scar tissue which would complicate PIV access
* Needle phobia
* Radiation / chemotherapy in the last year
* Received IV therapy in 14 days prior to study visit
* Severe dehydration on day of study visit
* Sick or had an infection in 14 days prior to study visit
* Tattoo(s) that severely limits vein visualization at a sensor monitoring location
* Unstable or uncontrolled cardiopulmonary disorder
* Uncontrolled seizures
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07311733
Study Brief:
Protocol Section:
NCT07311733